A case of acute myocardial infarction with repetitive stent thrombosis during emergent percutaneous coronary

Bunji Kaku1, Shoji Katsuda, Tomio Taguchi

  • 1Division of Cardiovascular Medicine, Toyama Red Cross Hospital, Toyama, Japan.

International Heart Journal
|February 28, 2009
PubMed

Insights

This case study highlights transient heparin resistance in acute myocardial infarction due to decreased antithrombin III activity. Prompt recognition and alternative anticoagulation are crucial for managing such complex cardiac events.

Area of Science:

  • Cardiology
  • Hematology

Background:

  • A 59-year-old female patient presented with acute anterior myocardial infarction.
  • She had a history of uncontrolled diabetes mellitus, hypertension, hyperlipidemia, obesity, and smoking.

Observation:

  • Coronary angiography revealed significant stenosis and dissection in the left anterior descending artery and left main trunk, necessitating complex stenting procedures.
  • Repetitive stent thrombosis occurred post-intervention despite adequate anticoagulation attempts with unfractionated heparin, showing prolonged activated coagulation time (ACT) and activated partial prothrombin time (aPTT).

Findings:

  • Heparin resistance was observed, characterized by a lack of prolonged ACT and aPTT despite high doses of heparin.
  • A transient decrease in antithrombin III activity (65%) was identified during the acute phase of myocardial infarction.
  • Administration of argatroban successfully achieved the desired anticoagulation effect, and antithrombin III activity normalized spontaneously in the chronic phase.

Implications:

  • This case underscores the importance of recognizing transient antithrombin III deficiency as a cause of heparin resistance in acute myocardial infarction.
  • Alternative anticoagulation strategies, such as argatroban, should be considered in patients with suspected heparin resistance.
  • Understanding these acute phase hematological changes is vital for optimizing treatment and improving outcomes in patients with ST-elevation myocardial infarction.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...